Business Segments Tenaya Therapeutics, Inc.
Stocks
TNYA
US87990A1060
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7880 USD | -4.44% |
|
-6.14% | +11.23% |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Biological Products | |||||||
Net Income | -72.72M | -124M | -124M | -111M | -90.6M | ||
Operating Income | -72.81M | -126M | -131M | -116M | -93.33M | ||
D&A | 2.96M | 6.47M | 8.69M | 8.47M | 8.44M | ||
EBT | -72.72M | -124M | -124M | -111M | -90.6M | ||
CAPEX | -25.12M | -20.63M | -1.24M | -1.02M | -618K | ||
Total Assets | 314M | 279M | 171M | 120M | 147M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Operating Income | -72.81M | -126M | -131M | -116M | -93.33M | ||
EBT | -72.72M | -124M | -124M | -111M | -90.6M | ||
Net Income | -72.72M | -124M | -124M | -111M | -90.6M | ||
CAPEX | -25.12M | -20.63M | -1.24M | -1.02M | -618K | ||
D&A | 2.96M | 6.47M | 8.69M | 8.47M | 8.44M | ||
Total Assets | 314M | 279M | 171M | 120M | 147M |
- Stock Market
- Stocks
- TNYA Stock
- Financials Tenaya Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
